HSINCHU, Dec. 2, 2025 /PRNewswire/ -- Amaran Biotech, a next-generation Contract Development and Manufacturing Organization (CDMO), announced that its self-developed, GMP-grade high-purity vaccine ...

BCC Research examines how AI is accelerating vaccine adjuvant discovery, optimizing formulations and improving ...

A biotech that lost federal funding Tuesday following Health Secretary Robert F. Kennedy Jr.’s edict that his agency’s pandemic preparedness division stop funding development of messenger RNA-based ...

Recently, Moderna has gained renewed attention for its mRNA technology after achieving positive results in personalized cancer vaccine trials. mRNA technology is establishing itself as a ...

The agreement, announced in New York on the margins of the 81st United Nations General Assembly, represents the first tranche ...

An international research team has identified a novel HIV antibody that targets the virus at a particularly vulnerable site and overcomes previous limitations of known antibodies. This study, led by ...

Vaxxinity Inc positions itself as a biotechnology company aiming to develop vaccines and immunotherapies based on a modular peptide vaccine platform. The company’s approach seeks to train the immune ...

Vaxcyte remains in focus after recent clinical and pipeline updates around its pneumococcal vaccine program, a key catalyst for a US-listed biotech tied to respiratory disease prevention. Vaxcyte is ...

India has in recent years emerged as the world’s largest vaccine producer and global supplier by volume, while its diverse ...

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...

The Life Sciences Innovation Forum (LSIF), the investment platform of the Riyadh Global Medical Biotechnology Summit (RGMBS 2026), brought 23 biotechnology companies from eight countries to Riyadh to ...

Add Yahoo as a preferred source to see more of our stories on Google. Health and Human Services Secretary Robert F. Kennedy Jr. revealed his agency will be cutting funding to mRNA development, calling ...